Journal of Neuroscience · 2001 · 119 citations · 63 references
Life SciencesNeurobiologyNeuroscienceCell SignalingMolecular NeuroscienceSignal TransductionAlzheimer DiseaseAmyloid FormationNeurodegeneration MechanismsNeurodegenerative DiseasesNeurodegenerative DisordersProtein Kinase CascadesAmyloid PlaquesAmyloidogenic ProteinsC-jun N-terminal Kinase SignalingJun N-terminal Kinase SignalingMitogen-activated Protein Kinase CascadesMitogen-activated Protein Kinase PathwaysP38 Mitogen-activated Protein Kinase SignalingWnt Signaling Cascades
Alzheimer's disease (AD) is a disorder of two pathologies: amyloid plaques, the core of which is a peptide derived from the amyloid precursor protein (APP), and neurofibrillary tangles composed of highly phosphorylated tau. Protein kinase C (PKC) is known to increase non-amyloidogenic alpha-secretase cleavage of APP, producing secreted APP (sAPPalpha), and glycogen synthase kinase (GSK)-3beta is known to increase tau phosphorylation. Both PKC and GSK-3beta are components of the wnt signaling cascade. Here we demonstrate that overexpression of another member of this pathway, dishevelled (dvl-1), increases sAPPalpha production. The dishevelled action on APP is mediated via both c-jun terminal kinase (JNK) and protein kinase C (PKC)/mitogen-activated protein (MAP) kinase but not via p38 MAP kinase. These data position dvl-1 upstream of both PKC and JNK, thereby explaining the previously observed dual signaling action of dvl-1. Furthermore, we show that human dvl-1 and wnt-1 also reduce the phosphorylation of tau by GSK-3beta. Therefore, both APP metabolism and tau phosphorylation are potentially linked through wnt signaling.
63